Instructions for Urolesan syrup bottle 180 ml
Composition
active ingredients: 100 ml of syrup contain fir oil – 0.419 g, peppermint oil – 0.105 g, wild carrot fruit extract liquid Extractum fructum Dauci sativi fluidum (1:1) (extractant 96% ethanol) – 1.204 g, hop cone extract liquid Extractum fructum Strobili lupuli fluidum (1:1) (extractant 96% ethanol) – 1.726 g, oregano herb extract liquid Extractum herbae Origani fluidum (1:1) (extractant 96% ethanol) – 1.195 g;
Excipients: polysorbate-80; citric acid, monohydrate; sorbic acid; sugar syrup; disodium edetate; purified water.
Dosage form
Syrup.
Main physicochemical properties: light yellow liquid with a greenish tint, with a specific odor. Opalescence is allowed.
Pharmacotherapeutic group
Drugs used in urology. ATX code G04B X.
Pharmacological properties
Pharmacodynamics
Combined herbal preparation. The components of the drug Urolesan® reduce inflammatory phenomena in the urinary tract and kidneys, promote increased blood circulation in the kidneys and liver, have a diuretic, antibacterial, choleretic effect, form a protective colloid in the urine and normalize the tone of the smooth muscles of the upper urinary tract and gallbladder. Urolesan® increases the excretion of urea and chlorides, promotes the excretion of small stones and sand from the bladder and kidneys.
Pharmacokinetics
The drug is well absorbed, its action begins in 20-30 minutes and lasts 4-5 hours. The maximum effect occurs in 1-2 hours. It is excreted through the digestive tract and kidneys.
Indication
Acute and chronic infections of the urinary tract and kidneys (cystitis and pyelonephritis); urolithiasis and uric acid diathesis (prevention of the formation of stones after their removal); chronic cholecystitis (including calculous), biliary dyskinesia, cholelithiasis.
Contraindication
- Hypersensitivity to the components of the drug;
- gastritis, gastric and duodenal ulcers;
- children with a history of seizures (fibrillary or not).
Interaction with other medicinal products and other types of interactions
Not studied.
Application features
Do not use the drug if the diameter of the stones exceeds 3 mm.
Patients with diabetes mellitus, as well as patients with elevated blood glucose levels, should be careful when using Urolesan® (the drug contains sugar syrup).
Use with caution in patients with bronchial asthma due to the risk of bronchospasm.
Use during pregnancy or breastfeeding
The use of the drug during pregnancy or breastfeeding has not been studied.
Ability to influence reaction speed when driving vehicles or other mechanisms
It was not studied.
Method of administration and doses
The drug should be taken orally before meals.
Recommended doses for adults: 1 teaspoon (5 ml) of syrup 3 times a day. In acute conditions (including renal and hepatic colic), the duration of the course of therapy is from 5 to 7 days, in chronic conditions - from 7 days to 1 month. In the event of renal and hepatic colic, the single dose can be increased to 2 teaspoons (10 ml) once, after which the next dose should be returned to the usual single dose (5 ml).
Recommended doses for children: 2-7 years old – 2-4 ml 3 times a day; 7-14 years old – 4-5 ml 3 times a day. Dosage is carried out using a syringe-doser.
Children
The drug should not be used in children under 2 years of age.
Overdose
In case of overdose, nausea, dizziness are possible.
Treatment: intensive warm drinking, rest, activated charcoal, atropine sulfate (0.0005-0.001 g).
Adverse reactions
Urolesan® is usually well tolerated. When using the drug, the following may occur:
Gastrointestinal: dyspeptic symptoms (including nausea, vomiting);
from the immune system: allergic reactions, including itching, facial flushing, skin rashes, urticaria, angioedema (burning sensation in the mouth, difficulty breathing, swelling of the face, tongue), anaphylactic shock;
from the central and peripheral nervous system: dizziness, general weakness, headache, ataxia, muscle tremor;
Cardiovascular system: hypotension, hypertension, bradycardia.
Expiration date
2 years.
Storage conditions
In the original packaging at a temperature not exceeding 25 °C. After opening, store for no more than 28 days at a temperature of 2 °C to 8 °C. Shake before use. Keep out of the reach of children.
Packaging
90 ml in a jar or bottle; 180 ml in a bottle. 1 jar or bottle in a pack together with instructions and a dosing syringe.
Vacation category
Without a prescription.
Producer
PJSC "Galychpharm".
Location of the manufacturer and its business address
Ukraine, 79024, Lviv, Opryshkivska St., 6/8.
